HLB이노베이션
024850KOSDAQ전자부품 제조업56.6 / 100
Reference Date: 2026-07-24
Company InformationBased on 2025 Annual Report
Business Overview
HLB Innovation specializes in semiconductor materials, particularly lead frames, leveraging growth trends in AI, HPC, and electric vehicles. The company mitigates economic volatility through strong customer partnerships and is expanding into EV component localization, securing new growth opportunities.
Number of Employees
61people
Average Salary
67.3M KRW
Score Calculation Basis
Detailed Financial Score
Higher than industry avg (caution)
Well below industry avg
Half of industry avg (excellent)
Avg ▲25.2% (2-year basis)
Avg ▼691.7% (2-year basis)
Avg ROE -7.9% (declining, 3yr)
Detailed News Sentiment
- Positive용량 높여도 ‘제한독성’ 없었다…HLB이노베이션 혈액암 CAR-T 1상...
HLB이노베이션의 CAR-T 치료제 SynKIR-310이 용량 증가에도 안전성을 입증하며 임상 진행에 긍정적 영향을 미침.
- PositiveHLB이노, 혈액암 CAR-T ‘SynKIR-310’ 임상 확대
HLB이노베이션의 CAR-T 치료제 SynKIR-310 임상 확대는 긍정적인 신호로, 시장에서의 성장 가능성을 높임.
- PositiveHLB이노베이션, 혈액암 CAR-T 1상서 초기 안전성 확인…용량군 ...
HLB이노베이션의 CAR-T 치료제 임상 1상에서 초기 안전성 확인 및 용량군 확대 소식으로 긍정적인 시장 반응 예상.
Detailed Momentum
52w lower range (29%)
1m -31.37% (strong drop)
Volume surge
Detailed Disclosure
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-07-22
- Neutral주식등의대량보유상황보고서(일반)2026-07-22
- Neutral전환가액의조정2026-07-21
- Neutral기업설명회(IR)개최2026-07-08
- Neutral주식등의대량보유상황보고서(일반)2026-07-07
